Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 2.6x - 2.9x | 2.8x |
| Historical Pb Multiple | 0.0x - 2.9x | 2.4x |
| Fair Value | ﷼44.91 - ﷼49.64 | ﷼47.27 |
| Upside | 10.6% - 22.3% | 16.4% |
| Benchmarks | - | Full Ticker |
| National Medical Care Company | 400,500.0% | SASE:4005 |
| Naba Al Saha Medical Services Company | 954,600.0% | SASE:9546 |
| Middle East Healthcare Company | 400,900.0% | SASE:4009 |
| Professional Medical Expertise Company | 957,400.0% | SASE:9574 |
| Arabian International Healthcare Holding Company | 953,000.0% | SASE:9530 |
| Scientific and Medical Equipment House Company | 401,400.0% | SASE:4014 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4005 | 9546 | 4009 | 9574 | 9530 | 4014 | |||
| SASE:4005 | SASE:9546 | SASE:4009 | SASE:9574 | SASE:9530 | SASE:4014 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 30.1% | NM- | 23.6% | NM- | NM- | -14.2% | ||
| 3Y CAGR | 29.8% | -5.5% | 154.0% | 38.8% | -26.5% | -24.9% | ||
| Latest Twelve Months | 23.8% | -58.4% | 1555.1% | 20.8% | 68.9% | -33.5% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 17.5% | 21.9% | 4.4% | 11.3% | 8.2% | 6.4% | ||
| Prior Fiscal Year | 22.3% | 28.7% | 0.6% | 10.8% | 3.2% | 6.3% | ||
| Latest Fiscal Year | 23.0% | 11.2% | 9.8% | 9.9% | 4.7% | 3.7% | ||
| Latest Twelve Months | 23.0% | 11.2% | 9.8% | 9.9% | 3.9% | 3.7% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 13.8% | 20.8% | 7.0% | 30.7% | 18.3% | 9.5% | ||
| Prior Fiscal Year | 17.7% | 33.8% | 1.3% | 33.7% | 6.6% | 10.0% | ||
| Latest Twelve Months | 19.3% | 11.5% | 19.1% | 32.4% | 11.3% | 6.4% | ||
| Next Fiscal Year | 18.7% | 14.7% | 15.9% | 39.1% | 24.8% | 11.2% | ||
| Two Fiscal Years Forward | 19.1% | 13.0% | 16.6% | 36.5% | 25.5% | 12.7% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 5.0x | 3.6x | 2.2x | 1.2x | 0.8x | 1.4x | ||
| Price / LTM EPS | 21.8x | 32.2x | 22.6x | 12.0x | 21.0x | 36.7x | ||
| Price / Book | 4.0x | 3.5x | 3.9x | 3.3x | 2.3x | 2.4x | ||
| Price / Fwd Book | 3.6x | 3.0x | 3.3x | 2.5x | 1.7x | 2.3x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 2.3x | 3.5x | 4.0x | |||||
| Historical P/B Ratio | 0.0x | 2.4x | 2.9x | |||||
| Selected P/B Multiple | 2.6x | 2.8x | 2.9x | |||||
| (x) Book Value | 511 | 511 | 511 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4005 | 9546 | 4009 | 9574 | 9530 | 4014 | |
| Value of Common Equity | 6,512 | 693 | 6,360 | 333 | 652 | 1,218 | |
| (/) Shares Outstanding | 44.9 | 10.5 | 92.0 | 3.5 | 19.8 | 30.0 | |
| Implied Stock Price | 145.20 | 66.00 | 69.10 | 95.00 | 32.95 | 40.60 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 145.20 | 66.00 | 69.10 | 95.00 | 32.95 | 40.60 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |